"The groundwork of all happiness is health." - Leigh Hunt

FDA approves updated non-mRNA COVID vaccine from Novavax

Oct. 4, 2023 – The Update Covid-19 vaccination The vaccine made by Novavax is now approved to be used within the U.S. and tens of millions of those doses are on their technique to pharmacies and other healthcare facilities.

Novavax CEO John Jacobs predicted it should take every week or less for vaccinations to succeed in consumers.

“Today's authorization of Novavax means people now have a choice of a protein-based, non-mRNA option to protect themselves from COVID-19, which is now the fourth leading cause of death in the United States,” Jacobs said within the statement. “In the coming days, individuals in the United States will be able to go to major pharmacies, doctor's offices, clinics and various government offices to receive an updated Novavax vaccine.”

The permit from the FDA comes as insurance and distribution Challenges have hampered adoption of updated vaccines from Pfizer and Moderna, that are already approved by the FDA. The CDC also approved the Novavax vaccine. Like the brand new Pfizer and Moderna vaccines, the Novavax shot has been tweaked to focus on evolved elements of the virus ahead of the colder months, when respiratory illnesses typically increase as people spend more time indoors.

The FDA said the Novavax shot is approved for anyone age 12 and older. Novavax uses a distinct technology to trigger protection than the mRNA shots from Pfizer and Moderna. Novavax works similarly to much older vaccines, including the tetanus shot for youngsters and the vaccines that prevent human papillomavirus (HPV) and hepatitis B virus, in response to a Summary from the Johns Hopkins Bloomberg School of Public Health.

In animal tests, the updated Novavax vaccine triggered immune responses against a number of the newer circulating variants. The Wall Street Journal reported.

Novavax has not been used as widely within the U.S. since it was approved much later within the pandemic in comparison with other COVID vaccines. As of May, nearly 90,000 doses of Novavax had been administered nationwide, in comparison with greater than 400 million doses of Pfizer and about 253 million doses of Moderna. CDC data showed.

According to a federal estimate, at the least two million people within the United States have received the updated COVID-19 vaccine up to now, although the CDC is just not currently releasing regular updates on vaccination numbers because it used to.

Last month, the CDC really helpful that everybody ages 6 months and older get an updated COVID-19 vaccine this fall and winter.